sales@jinjingroup.com

  News Introduction

Phenylpiracetam(cas 77472-70-9) treat alzheimer's disease

Date : 2016/9/10 11:02:44

Alzheimer's patients when psychotherapy and other non-drug therapy invalid, we need to take medication intervention such as phenylpiracetam(cas 77472-70-9). Drug treatment of senile dementia, the most important choice for nootropic drugs, designed to improve brain function in patients. For AD patients may experience depression, mental, anxiety and other symptoms, sometimes symptomatic of drug use, but in clinical practice should choose carefully.

Behavioral of psychological symptoms (BPSD) influenced by many factors, in general, mainly due to degeneration of the nervous system, resulting in degeneration of damaged nerve network, which led to the overall decline in the patient's mental capacity, mental behavioral symptoms. Meanwhile, the decline in this ability and also the patients themselves, caregivers, environmental factors are closely related. Once patients with BPSD symptoms should carefully analyze the causes of the disease, symptomatic management. If BPSD symptoms are due to the factors which should be used as a non-drug therapy psychotherapy; and because of the nervous system disease causes BPSD symptoms, it is necessary to adopt phenylpiracetam (cas 77472-70-9) intervention.

In terms of the treatment of senile dementia BPSD preferred non-drug treatment - psychosocial treatment; and must be used when drug treatment, drug treatment should be nootropics such as phenylpiracetam (cas 77472-70-9) as a basis for treatment; in BPSD case to patients with pain and other treatments ineffective, prudent use of antidepressants and antipsychotics.